Search results
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 5 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Vicore to kickstart Phase IIb IPF trial for buloxibutid
Clinical Trials Arena via Yahoo Finance· 1 day agoVicore Pharma is looking to move ahead with the Phase IIb trial of its lead pipeline candidate...
Ozempic Maker Plans to Study the Drug’s Effects on Alcohol Consumption
People via Yahoo News· 2 days agoNovo Nordisk told CNN in a statement that this new trial will look at whether the drug can improve...
EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of...
The Herald Journal· 6 days agoMajor Milestone for EVŌQ Nano's Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks· 14 hours agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
89bio begins Phase III trial of treatment for steatohepatitis with cirrhosis
Clinical Trials Arena via Yahoo Finance· 6 days agoSubjects will then self-administer pegozafermin using its commercial liquid formulation, which is designed for subcutaneous injection. The primary endpoint for an interim analysis of
Novel Drugs for IPF Improve Lung Function in Mid-Stage Trials
MedPage Today· 2 days ago'These are among the two most exciting sets of results we've seen,' researcher says
Sub-Four-Minute Mile Runners Outlive General Population
Medscape· 14 hours agoElite athletes who have run a mile in less than 4 minutes tend to live longer than the general...
Don't Miss the Dx: Unexplained Renal Symptoms in Young Adult
Medscape· 2 days agoLearn more with this brief guide to the presentation, differential diagnosis, and management of this...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 22 hours agoAP01 (Inhaled Pirfenidone) Treatment Demonstrated Substantially Improved Efficacy and Tolerability Out to 3.5 Years Compared to Historical Data with Oral Pirfenidone Additional Poster Presentations Highlighted Post-hoc Analyses of the ATLAS
